Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™

Implantica Liechtenstein

View original content:https://www.prnewswire.co.uk/news-releases/implantica-announces-finalization-of-remarkable-5-year-pivotal-ce-mark-study-results-and-gears-up-for-the-module-2-submission-of-pma-application-to-fda-for-refluxstop-302258272.html